These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32872629)

  • 1. Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19.
    Albani F; Fusina F; Giovannini A; Ferretti P; Granato A; Prezioso C; Divizia D; Sabaini A; Marri M; Malpetti E; Natalini G
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32872629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Hydroxychloroquine and Azithromycin Combination Therapy on Hospital Mortality in COVID 19 Pneumonia Patients.
    Özuygur Ermiş SS; Ergan B; Kaçmaz Başoğlu Ö; Ercan S; Korkmaz Ekren P; Kuruüzüm Z; Özhan MH; Sayiner AA; Savran Y; Sertöz ŞR; Taşbakan MS; Kilinç O; Sayiner A
    Turk J Med Sci; 2021 Aug; ():. PubMed ID: 34344140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.
    Lauriola M; Pani A; Ippoliti G; Mortara A; Milighetti S; Mazen M; Perseghin G; Pastori D; Grosso P; Scaglione F
    Clin Transl Sci; 2020 Nov; 13(6):1071-1076. PubMed ID: 32926573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis.
    Arfaras-Melainis A; Tzoumas A; Kokkinidis DG; Salgado Guerrero M; Varrias D; Xu X; Cerna L; Avendano R; Kemal C; Palaiodimos L; Faillace RT
    J Cardiovasc Dev Dis; 2021 May; 8(5):. PubMed ID: 34068104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
    El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
    Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.
    Magagnoli J; Narendran S; Pereira F; Cummings TH; Hardin JW; Sutton SS; Ambati J
    Med; 2020 Dec; 1(1):114-127.e3. PubMed ID: 32838355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort.
    Abdulrahman A; AlSayed I; AlMadhi M; AlArayed J; Mohammed SJ; Sharif AK; Alansari K; AlAwadhi AI; AlQahtani M
    Infect Dis Ther; 2021 Mar; 10(1):439-455. PubMed ID: 33484407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19.
    Magagnoli J; Narendran S; Pereira F; Cummings T; Hardin JW; Sutton SS; Ambati J
    medRxiv; 2020 Apr; ():. PubMed ID: 32511622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study.
    Huang HD; Jneid H; Aziz M; Ravi V; Sharma PS; Larsen T; Chatterjee N; Saour B; Aziz Z; Nayak H; Trohman RG; Krishnan K
    Cardiol Ther; 2020 Dec; 9(2):523-534. PubMed ID: 33058086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia.
    Go RC; Nyirenda T
    Front Pharmacol; 2022; 13():935370. PubMed ID: 36238570
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV).
    Sobngwi E; Zemsi S; Guewo M; Katte JC; Kouanfack C; Mfeukeu L; Zemsi A; Wasnyo Y; Ntsama Assiga A; Ndi Manga A; Sobngwi-Tambekou J; Ngatchou W; Moussi Omgba C; Mbanya JC; Ongolo Zogo P; Fouda PJ
    Cureus; 2023 Sep; 15(9):e45619. PubMed ID: 37868535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of in-hospital treatment of Covid-19 infection with low-dose hydroxychloroquine and azithromycin in hospitalized patients: A retrospective controlled cohort study.
    Meeus G; Van Coile F; Pottel H; Michel AS; Vergauwen O; Verhelle K; Lamote S; Leys M; Boudewijns M; Samaey P
    New Microbes New Infect; 2023 Oct; 55():101172. PubMed ID: 37842131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Hydroxychloroquine and Azithromycin Combination Use in COVID-19 Patients - An Umbrella Review.
    Nag K; Tripura K; Datta A; Karmakar N; Singh M; Singh M; Singal K; Pradhan P
    Indian J Community Med; 2024; 49(1):22-27. PubMed ID: 38425958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.
    Lane JCE; Weaver J; Kostka K; Duarte-Salles T; Abrahao MTF; Alghoul H; Alser O; Alshammari TM; Biedermann P; Banda JM; Burn E; Casajust P; Conover MM; Culhane AC; Davydov A; DuVall SL; Dymshyts D; Fernandez-Bertolin S; Fišter K; Hardin J; Hester L; Hripcsak G; Kaas-Hansen BS; Kent S; Khosla S; Kolovos S; Lambert CG; van der Lei J; Lynch KE; Makadia R; Margulis AV; Matheny ME; Mehta P; Morales DR; Morgan-Stewart H; Mosseveld M; Newby D; Nyberg F; Ostropolets A; Park RW; Prats-Uribe A; Rao GA; Reich C; Reps J; Rijnbeek P; Sathappan SMK; Schuemie M; Seager S; Sena AG; Shoaibi A; Spotnitz M; Suchard MA; Torre CO; Vizcaya D; Wen H; de Wilde M; Xie J; You SC; Zhang L; Zhuk O; Ryan P; Prieto-Alhambra D;
    Lancet Rheumatol; 2020 Nov; 2(11):e698-e711. PubMed ID: 32864627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study.
    Gentry CA; Humphrey MB; Thind SK; Hendrickson SC; Kurdgelashvili G; Williams RJ
    Lancet Rheumatol; 2020 Nov; 2(11):e689-e697. PubMed ID: 32984847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational medications in 9,638 hospitalized patients with severe COVID-19: lessons from the "fail-and-learn" strategy during the first two waves of the pandemic in 2020.
    Delgado AC; Cornett B; Choi YJ; Colosimo C; Stahel VP; Dziadkowiec O; Stahel PF
    Patient Saf Surg; 2023 Apr; 17(1):7. PubMed ID: 37041643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Umbrella Review of Clinical Efficacy and Adverse Cardiac Events Associated with Hydroxychloroquine or Chloroquine with or Without Azithromycin in Patients with COVID-19.
    Shahsavarinia K; Ghojazadeh M; Ghabousian A; Hatefnia F; Soleimanpour M; Soleimanpour H
    Anesth Pain Med; 2021 Aug; 11(4):e115827. PubMed ID: 34692436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine is protective to the heart, not harmful: a systematic review.
    Prodromos CC; Rumschlag T; Perchyk T
    New Microbes New Infect; 2020 Sep; 37():100747. PubMed ID: 32839670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome - Clearing Safety Issues and Good Clinical Practice.
    Dutta D; Sharma M; Sharma R
    Eur Endocrinol; 2020 Oct; 16(2):109-112. PubMed ID: 33117441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
    Lacout A; Marcy PY; Perronne C
    Clin Microbiol Infect; 2021 Jan; 27(1):134-135. PubMed ID: 32987193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.